Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
Wiener
Y
Y
Department of Surgery, Henry Ford Hospital, Detroit, Michigan 48202.
Nakhleh
R E
RE
Kupin
W L
WL
Lee
M
M
Escobar
F S
FS
Venkat
K K
KK
Mozes
M F
MF
D000704:Analysis of Variance; D001707:Biopsy, Needle; D004351:Drug Resistance; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006085:Graft Survival / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology* / Q000502:physiology; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D012044:Regression Analysis; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use; D016896:Treatment Outcome
D016853:Muromonab-CD3; D013256:Steroids